Who owns Alnylam Pharmaceuticals?
Key information on Alnylam Pharmaceuticals (Ticker: ALNY)
- CUSIP: 02043Q107
Who owns Alnylam Pharmaceuticals?
Is ALNY a good stock to own? Find out who bought Alnylam Pharmaceuticals, who sold Alnylam Pharmaceuticals (ALNY) stock, and who holds a large position in Alnylam Pharmaceuticals.
- Vanguard owns 2.86M shares worth $69.65M
- HealthCor Management owns 1.80M shares worth $16.87M
- T. Rowe Price Associates owns 1.71M shares worth $41.58M
- STATE STREET CORPORATION owns 1.66M shares worth $40.42M
- HealthCor Management owns 1.45M shares worth $35.34M
- Bridger Management owns 1.37M shares worth $33.31M
- Deerfield Management Company owns 1.22M shares worth $29.77M
- Columbia Wanger Asset Management owns 1.10M shares worth $26.76M
- Gilder, Gagnon, Howe & Co owns 1.09M shares worth $26.67M
- Camber Capital Management owns 1000000 shares worth $18.79M
- Jennison Associates owns 965734 shares worth $23.53M
- BAILLIE GIFFORD & CO owns 747400 shares worth $6.08M
- S.A.C. Capital Advisors owns 744873 shares worth $18.15M
- CITADEL ADVISORS owns 725620 shares worth $17.68M
- Columbus Circle Investors owns 588320 shares worth $14.34M
- Broadfin Capital owns 581018 shares worth $6.43M
- Abingworth owns 514053 shares worth $12.53M
- Driehaus Capital Management owns 391791 shares worth $9.55M
- Charles Schwab Bank owns 358239 shares worth $14.70M
- Wells Fargo & Company owns 340612 shares worth $3.96M
- Oxford Asset Management owns 339082 shares worth $3.75M
- Renaissance Technologies owns 298600 shares worth $3.48M
- Polar Capital owns 295000 shares worth $7.19M
- D. E. Shaw & Co owns 292766 shares worth $7.13M
- RA Capital Management owns 250000 shares worth $2.77M
- GOLDMAN SACHS owns 237877 shares worth $5.80M
- TIAA-CREF Investment Management owns 228575 shares worth $5.57M
- Norges Bank Investment Management owns 207013 shares worth $3.78M
- Geode Capital Management owns 204735 shares worth $4.99M
- Bailard owns 190000 shares worth $2.10M
- Sigma Capital Management owns 180000 shares worth $1.47M
- Inves owns 168485 shares worth $4.11M
- RCM Capital Management owns 158536 shares worth $1.75M
- Perceptive Advisors owns 157000 shares worth $3.83M
- Kerrisdale Advisers owns 139851 shares worth $3.41M
- Millennium Management owns 135109 shares worth $2.47M
- Franklin Resources owns 132100 shares worth $3.22M
- Credit Suisse AG owns 127121 shares worth $3.30M
- Allianz Asset Management AG owns 126408 shares worth $3.08M
- Charles Schwab Investment Management owns 120527 shares worth $2.84M
- ALLIANCEBERNSTEIN owns 117649 shares worth $2.87M
- Jefferies owns 115305 shares worth $1.28M
- Spark LP/DE owns 113500 shares worth $1.26M
Who sold Alnylam Pharmaceuticals?
- Barclays sold on June 30, 2011
- WEISS MULTI-STRATEGY ADVISERS sold on June 30, 2011
- Jacobs Levy Equity Management sold on March 31, 2011
- Baker Bros. Advisors sold on March 31, 2011
- FMR sold on Dec. 31, 2010
- OrbiMed Advisors sold on Dec. 31, 2010
- Name Aletheia Research and Management sold on Dec. 31, 2010
- Tudor Investment Corporation sold on March 31, 2006
Funds that own ALNY also own:
- Abbott Laboratories (ABT)
- Incyte Corporation (INCY)
- InterMune (ITMN)
- Johnson & Johnson (JNJ)
- Pfizer (PFE)
- Vertex Pharmaceuticals Incorporated (VRTX)
- Universal Health Services (UHS)
- ArthroCare Corporation (ARTC)
- PerkinElmer (PKI)
- eHealth (EHTH)
- Magellan Health Services (MGLN)
- Humana (HUM)
- ArQule (ARQL)
- Quest Diagnostics Incorporated (DGX)
- Salix Pharmaceuticals (SLXP)
- Nektar Therapeutics (NKTR)
- Wright Medical (WMGI)
- CorVel Corporation (CRVL)
- Rigel Pharmaceuticals (RIGL)
- Alnylam Pharmaceuticals (ALNY)
- Celldex Therapeutics (CLDX)